FDA Approves Treatment for Moderate-to-Severe Chronic Hand Eczema
Regulatory approval is based on clinical trials showing improvements in symptom severity and treatment success at 16 weeks.
Regulatory approval is based on clinical trials showing improvements in symptom severity and treatment success at 16 weeks.
Researchers found participation among underrepresented racial and ethnic groups increased far beyond national population growth.